Skip to main content
. 2009 Mar 19;3:4. doi: 10.1186/1751-0759-3-4

Table 4.

Simple correlation coefficients (r) and standard regression coefficients by hierarchical stepwise multiple regression (β) between baseline variables and HbA1c at 1 year follow-up of patients with type 2 diabetes (n = 290).

Hierarchical stepwise regression analysis

Simple correlation Model 1 Model 2 Model 3 Model 4 Model 5






Baseline variables r P β P β P β P β P β P






Sex (male = 1, female = 0) -0.106 0.071 - - - - - - - - - -
Age -0.219 <0.001 -0.180 0.001 -0.153 <0.001 -0.154 0.001 - - - -
Duration of illness 0.016 0.788 - - - - - - - - -
Treatment regimen
(diet only = 1, medication = 0)
-0.318 <0.001 -0.294 <0.001 -0.278 0.001 -0.274 <0.001 -0.155 0.001 -0.155 0.001
No. of microvascular
complications of diabetes
0.102 0.082 - - - - - - - - - -
DTSQ -0.202 0.001 NI NI -0.115 0.030 NI NI - - NI NI
W-BQ12 -0.137 0.020 NI NI - - - - - - - -
PAID 0.220 <0.001 NI NI NI NI 0.140 0.014 NI NI - -
SES -0.095 0.108 NI NI - - - - - - - -
Social Support Scale -0.054 0.358 NI NI - - - - - - - -
Self-Efficacy Scale -0.166 0.001 NI NI - - - - - - - -
HbA1c 0.675 <0.001 NI NI NI NI NI NI 0.638 <0.001 0.634 <0.001
Adjusted R2 0.127 0.138 0.144 0.479 0.474
F 22 <0.001 16.2 <0.001 17.0 <0.001 132 <0.001 130 <0.001

Medication: oral hypoglycemic agents, or insulin, or insulin plus oral hypoglycemic agents. DTSQ, Diabetes Treatment Satisfaction Questionnaire; W-BQ12, Well-being Questionnaire12; PAID, Problem Areas in Diabetes Scale; SES, Self-Esteem Scale. Each measure is detailed in the footnotes of Table 1. R2, multiple coefficient of determination. NI, not included. Model 1, adjusted for sex, age, duration of illness, treatment regimen, number of microvascular complications of diabetes; Model 2, adjusted for Model 1 and DTSQ, W-BQ12, SES, Social Support Scale, Self-Efficacy Scale; Model 3, adjusted for Model 1 and W-BQ12, PAID, SES, Social Support Scale, Self-Efficacy Scale; Model 4, adjusted for Model 2 and HbA1cat baseline; Model 5, adjusted for Model 3 and HbA1c at baseline.